We are a biopharmaceutical company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route.
Newark, CA
Joined October 2018
- Tweets164
- Following72
- Followers184
- Likes189
The RESTORE-1 study for Atrial Fibrillation (AF) is actively recruiting patients diagnosed with AF for participation. You can access study related information and find a participating hospital near you at:
restore-1study.com/us-en
InCarda Therapeutics retweeted
Participate in atrial fibrillation (#afib) patient advocacy training program. US candidates only. Please share, @nmarrouche @natale_md @aalahmadmd @LuigiDiBiaseMD
stopafib.org/afib-news-event…
We want to welcome Robert Lisicki to the InCarda Therapeutics family as our new CEO and Board Member.
And, we want to thank Grace Colón for nearly a decade of dedication to InCarda and patients living with atrial fibrillation.
tinyurl.com/5b6ujwem
Proud of our very own @ColonGraceE for being recognized by @CABiotech!
This #HispanicHeritageMonth, we recognize Grace E. Colón. @ColonGraceE, the President and Chief Executive Officer of InCarda Therapeutics, Inc. who brings years of experience in biopharma, genomics, healthcare, and industrial biotechnology. bit.ly/3qp2URm
InCarda Therapeutics retweeted
Consider joining us for Restoring Life’s Rhythm Webinars with Drs. Al-Ahmad (@aalahmadmd) & Colombowala (@RhythmMD). Hosted by #Medtronic for #AfibAwarenessMonth #atrialfibrillation #cardiacablation #heartmonitoring Please share
secure.medtronicinteract.com…
InCarda Therapeutics retweeted
Help patients learn about the role of rhythm control in managing #afib. #AfibMonth #AfibAwarenessMonth #CardioTwitter #ePeeps #atrialfibrillation @EPrystowskyonEP
@DebbeMcCall @HRSonline @HeartRhythmTV @natale_md Please share
InCarda Therapeutics retweeted
Apple adds new atrial fibrillation feature to watchOS 9
It tracks the amount of time you spend in #Afib bit.ly/3B0dG5P
InCarda Therapeutics retweeted
September is National Atrial Fibrillation Awareness Month! Help patients learn about the importance of getting in rhythm & staying in rhythm.
#StopAfib #AfibAwarenessMonth @DebbeMcCall #CardioTwitter #ePeeps #afib #atrialfibrillation #AfibMonth youtube.com/watch?v=fwuC7nPP…
We presented additional Phase 2 data on oral inhaled flecainide for acute cardioversion of paroxysmal atrial fibrillation at ESC last month!
#afib #epeeps #innovation #biotech
tinyurl.com/373de6fx
Today marks the start of National Atrial Fibrillation Awareness Month.
At InCarda, we are driven by our desire to help empower patients living with AFib to have more control over their disease.
#afibmonth22 #EPeeps #stopafib #afib
Another awesome patient conference from @stopafib in the books! Very informative content presented by world-class providers. Some highlights: treatment options for AF, importance of rhythm control and the role of health tech in AF and drug monitoring.
#stopafib22 #epeeps
We’re excited to be here live in Dallas to support patients living with atrial fibrillation! Kudos to the StopAFib team! @MelanieHills #stopafib22
InCarda Therapeutics retweeted
So proud of this team right here! @OhioHealth #AfibClinic reaching the 5K patient milestone. Truly going above and beyond to deliver excellent #teambasedcare for our patients! @AnishAminEP @beth_loe @SreeBillakanty @badinmd @megan_labreck #EPeeps #teamworkmakesthedreamwork
We are excited to share that the first patient has been enrolled into our Phase 3 RESTORE-1 pivotal study. A huge milestone for InCarda and for patients with atrial fibrillation that we hope to serve!
lnkd.in/euhcKQDE
#innovative #EPeeps
We will be there! #Stopafib22
Last Call: Early Bird Registration (save $30) for Get in Rhythm. Stay in Rhythm. Atrial Fibrillation Patient Conference (Dallas or livestream). #StopAfib22 @DebbeMcCall @elizgreene @S_NarayanMD @VivekReddyMD
getinrhythm.com
ICYMI: We presented some exciting data over the weekend at this years #HRS2022
bit.ly/3vXtraT
We are excited to announce publication of our Phase 2 INSTANT study results in @CircAHA. Even more flattering is that the publication was "Editor's Pick" for this edition! #Epeeps #atrialfibrillation #afib #biotech #pharmaceuticals Check it out: tinyurl.com/ypyupfw3